Jin et al. [72] fabricated PLGA-based nanoparticles coated with human cancer cell membrane fractions and reported that these nanoparticles selectively target cancer cells due to the presence of intact membrane-associated proteins including CXCR4 and CD44. Here, CXCR4 is linked to cancer.